Mohammad Masjedizadeh
Technik-/Wissenschafts-/F&E-Leiter bei PROTAGONIST THERAPEUTICS, INC.
Profil
Mohammad Masjedizadeh is currently the Chief Technical Officer & Executive VP at Protagonist Therapeutics, Inc. Prior to this, he was the Senior Director-Technical Operations at Principia Biopharma, Inc. from 2012 to 2017.
He also worked at Roche Pharmaceuticals, Inc. and Roche Palo Alto LLC as the Director-Drug Substance & Supply from 1991 to 2012.
Dr. Masjedizadeh holds a doctorate degree from the University of California, Santa Barbara.
Aktive Positionen von Mohammad Masjedizadeh
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2021 |
Ehemalige bekannte Positionen von Mohammad Masjedizadeh
| Unternehmen | Position | Ende |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2012 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Mohammad Masjedizadeh
| University of California, Santa Barbara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
